Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Baqsimi (glucagon) for the Treatment of Severe Hypoglycaemia

Drug Name

Baqsimi™ (glucagon)

Developers

Locemia Solutions and Eli Lilly

Therapy Class

Antihypoglycaemic agent

Product Description

Polypeptide hormone

Current Indication

Severe hypoglycaemia

Market Sector

Diabetes

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top